Fertility and Sterility/LinkedIn
Feb 2, 2026, 13:04
Optimal GnRH Agonist Dosage for Oocyte Maturation – Fertility and Sterility
Fertility and Sterility shared a post on LinkedIn:
“Optimal gonadotropin-releasing hormone agonist dosage for oocyte maturation in low-prognosis patients: Interim analysis of a randomized controlled trial
Title: Optimal gonadotropin-releasing hormone agonist dosage for oocyte maturation in low-prognosis patients: interim analysis of a randomized controlled trial in Patient-Oriented Strategies Encompassing IndividualizeD Oocyte groups 3 and 4
Authors: Anjali Gahlan, Matheus Roque, Akanksha Jangid, Amrita Das, Pawan Yadav, Shashank Sangoudar, Kshitiz Murdia, Amol Lunkad, Vipin Chandra, Nitiz Murdia, Isha Suwalka, Walmik Mistari
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Sep 15, 2026, 18:18A PCOS Diagnosis Can Stay in the Background of Every Fertility Conversation – Banker IVF and Women’s Hospital
-
Sep 15, 2026, 18:15The Difference Between Ovulation Induction and Ovarian Stimulation – Fertility Plus
-
Sep 15, 2026, 18:13Ritu Anand: What Would I Tell an IVF Couple in the 1980s?
-
Sep 15, 2026, 18:11STP Curriculum Feedback Survey – The Association of Reproductive and Clinical Scientists
-
Sep 15, 2026, 18:09Khushi Mishra: ICSI – Where Precision Meets the Possibility of Life
-
Sep 15, 2026, 18:06Khalil Faaed: The Future of niPGT-A Is Not Just Non-Invasive…
-
Sep 15, 2026, 18:04Anuradha Housnur: ICSI Is Not About Injecting the Sperm…
-
Sep 15, 2026, 18:02Snehal Kaware: Can an Oocyte With a Vacuole Still Fertilize?
-
Sep 15, 2026, 17:59Kanishka Gaur: Amenorrhea Is a Symptom, Not a Diagnosis